RPG Life Sciences share news and announcements
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
Last close ₹2,619.60down ₹160.60 (5.78%)BSE ₹2,618.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,780.20.
52-week range of traded prices to 23 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,333 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 36.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 7.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.92%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 21.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- 21.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,53144.4% delivered
RPG Life Sciences share news and announcements
679 announcements, routine notices left out, newest first. Page 14 of 14.
May 2010
4 May · Board meeting
Inter alia, to consider and approve the following: (1) Audited Financial Results for the year ended on March 31, 2010; and (2) Recommendation of dividend for the year 2009-10, if any.
Apr 2010
5 Apr · Management
Mr.Arvind Vasudeva, Managing Director of the company has resigned from the services and he will be relieved on April 09, 2010. Further, Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company with effect from April 09, 2010.
Mar 2010
31 Mar · Issue and allotment of shares
Committee of Directors at its meeting held on March 31, 2010 has issued and allotted 7,00,000 equity shares of face value of Rs.8/- each at a price of Rs.23.70 per share including premium of Rs.15.70 per share, to Petrochem International Limited, on conversion of equivalent number of convertible warrants earlier issued to Petrochem International Limited on preferential basis, in accordance with the SEBI Guidelines for Preferential Issues.
Jan 2010
7 Jan · Board meeting
Meeting on 19 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
20 Oct · Board meeting
Meeting on 28 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
11 Sep · Meeting
Copy of the Proceedings of the Annual General Meeting of the Company held on August 26, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
26 Aug · Dividend
Company has declared the dividend at Rs. 1.20 per share for the year ended March 31, 2009 at the Annual General Meeting of the Company held on August 26, 2009. The said dividend will be paid to the eligible members on September 16, 2009.14 Aug · Meeting
Annual General Meeting of the Members of the Company will be held on August 26, 2009.10 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Aug · Business
RPG Life Sciences is launching "Sirolimus", a Biotech product. Sirolimus is the 2nd Biotech immunosuppressant API of the Company. Sirolimus technology is developed end-to-end by the Company through an in house R&D effort
Jul 2009
20 Jul · Corporate action
Register of members and share transfer books of the company will remain closed from August 01, 2009 to August 26, 2009 (both days inclusive) for the purpose of Annual General Meeting and payment of equity dividend of Rs.1.20 per share (15%) for the year ended March 31, 2009, if declared at the said Annual General Meeting.20 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
25 Jun · Dividend
Board of Director of the Company at its meeting held on June 25, 2009 has recommended an equity dividend of Rs.1.20 per share for the year ended March 31, 2009, subject to the approval of the members.17 Jun · Board meeting
Inter alia, to consider and approve the following: (1) Audited financial results for the year ended on March 31, 2009; and (2) Recommendation of dividend for the year 2008-09, if any.
Apr 2009
8 Apr · Results
Company would be submitting the audited financial results for the year ended March 31, 2009 within 3 months from the end of financial year. In view of this, the Company will not be submitting / publish the unaudited financial results for the last quarter ended March 31, 2009.
Mar 2009
30 Mar · Business
Committee of Directors at its meeting held on March 30, 2009 has allotted 15,00,000 convertible warrants to Petrochem International Limited and 6,38,000 convertible warrants to KEC Holdings Limited, both Promoter Group Companies, on preferential basis, convertible into equivalent number of equity shares of face value of Rs.8/- each at a premium of Rs. 15.70 per share, in one or more tranches, within 18 months from the date of allotment of the warrants.27 Mar · Results
In terms of the resolution passed by the Board of Directors on February 20, 2009, the Company conducted the postal ballot under Section 192A of the Companies Act, 1956 read with the Companies (Passing of Resolution by the Postal Ballot) Rules, 2001 in respect of Special Resolution under Section 81(1A) of the Companies Act, 1956 for issue and allotment of 15,00,000 convertible warrants to Petrochem International Limited and 6,38,000 convertible warrants to KEC Holdings Limited, both Promoter Group Companies, on preferential basis, in accordance with SEBI Guidelines for Preferential Issues. The above resolution is approved by the shareholders by requisite majority. A copy of the result of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.16 Mar · Meeting
Pursuant to Section 192A of the Companies Act, 1956, read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001, the Company is seeking approval of the shareholders by postal ballot in respect of following resolution : Special Resolution for Raising of additional long term funds through issue of convertible warrants to the promoters on Preferential Basis. The Board of Directors of the Company on February 20, 2009 has appointed Mr. Ashish Kumar Jain, Practicing Company Secretary as the Scrutinizer to conduct the voting through postal ballot in a fair and transparent manner. The duly completed Postal Ballot Forms should reach the Scrutinizer before the close of working hours on or before March 26, 2009. The Scrutinizer will submit his report to the Chairman after completion of scrutiny and the results of the postal ballot will be announced on or after March 26, 2009. A copy of the notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
20 Feb · Business
Board of Directors of the Company on February 20, 2009 has approved the following: (1) Issue of 15,00,000 convertible warrants to Petrochem International Limited and 6,38,000 convertible warrants to KEC Holdings Limited, both Promoter Group Companies, on preferential basis, aggregating to 21,38,000 convertible warrants, convertible into equivalent number of equity shares of face value of Rs.8/- each at a premium on full payment, in one or more tranches, within 18 months from the date of allotment of the warrants, at a price to be determined in accordance with the Guidelines for Preferential Issues contained In Chapter XIII of the Securities and Exchange Board of India (Disclosure & Investor Protection) Guidelines, 2000, considering February 24, 2009 as the Relevant Date for this purpose. The aforesaid issue of convertible warrants to the Promoters is subject to the approval of the shareholders of the Company. (2) Conduct of postal ballot for seeking the approval of the shareholders or the Company for above preferential issue.
Jan 2009
21 Jan · Board meeting
Meeting on 29 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”9 Jan · Management
Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009.
Oct 2008
23 Oct · Management
Board of Directors of the Company at its meeting held today i.e. October 23, 2008, has appointed Mr. Ajit Singh Chouhan as an Additional Director of the Company.15 Oct · Board meeting
Meeting on 23 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Aug 2008
7 Aug · Meeting
Copy of Notice of Annual General Meeting of the Company to be held on August 27,2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
18 Jul · Board meeting
Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”16 Jul · Corporate action
Register of members and share transfer books of the company will remain closed from August 13, 2008 to August 27, 2008 (both days inclusive) for the purpose of Annual General Meeting and payment of dividend (15%), if declared.2 Jul · Updates
Boards of Directors at its meeting held on June 30, 2008 has adopted the accounts for the year ended on March 31, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
30 Jun · Dividend
Board of Directors of the Company in its meeting held on June 30, 2008, has recommended dividend @ 15% (Rs 1.20 per share) for the period ended on March 31, 2008. This will absorb Rs 2.02 crores including dividend distribution tax.17 Jun · Board meeting
Inter-alia, to consider and approve the audited financial results for the period ended on March 31, 2008.